Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL924461

COc1cccc(CC(=O)Nc2cc(-c3sc(NC(C)=O)nc3C)cnc2Cl)c1.O=C(O)C(F)(F)F

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 6/20 0.54
PIK3CB P42338 6/20 0.54
PIK3CD O00329 6/20 0.54
PIK3CG P48736 5/20 0.54
RIPK1 Q13546 1/20 0.54
PI4KB Q9UBF8 6/20 0.49
ALDH1A1 P00352 2/20 0.48
RXFP1 Q9HBX9 1/20 0.48
CSNK1D P48730 2/20 0.47
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
RAB9A P51151 1/20 0.45
CYP3A4 P08684 1/20 0.44
ROCK1 Q13464 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL924624 0.94 PIK3CA (0.58) PIK3CAPIK3CBPIK3CDPIK3CGRIPK1
Trifluoroacetic Acid SCHEMBL924629 0.92 RIPK1 (0.55) PIK3CAPIK3CBPIK3CDPIK3CGRIPK1
Trifluoroacetic Acid SCHEMBL924714 0.90 RIPK1 (0.65) PIK3CAPIK3CBPIK3CDPIK3CGRIPK1
SCHEMBL924994 0.86 PIK3CA (0.59) PIK3CAPIK3CBPIK3CDPIK3CGRIPK1
SCHEMBL924535 0.85 RIPK1 (0.71) PIK3CAPIK3CBPIK3CDPIK3CGRIPK1
Trifluoroacetic Acid SCHEMBL926033 0.84 PIK3CB (0.73) PIK3CAPIK3CBPIK3CDPIK3CGPI4KB
Trifluoroacetic Acid SCHEMBL924653 0.83 PIK3CB (0.62) PIK3CAPIK3CBPIK3CDPIK3CGRIPK1
SCHEMBL924462 0.80 PIK3CA (0.53) PIK3CAPIK3CBPIK3CDPIK3CGPI4KB
Trifluoroacetic Acid SCHEMBL925885 0.79 PIK3CB (0.56) PIK3CAPIK3CBPIK3CDPIK3CGRIPK1
Trifluoroacetic Acid SCHEMBL925872 0.79 PIK3CD (0.70) PIK3CAPIK3CBPIK3CDPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7868188-B2 5-heteroaryl thiazoles and their use as PI3K inhibitors ASTRAZENECA AB (SE) 2011-01-11 US disclosed
EP-1841763-B1 5-HETEROARYL THIAZOLES AND THEIR USE AS PI3K INHIBITORS ASTRAZENECA AB (SE) 2010-06-30 EP disclosed
US-20080132502-A1 5-Heteroaryl Thiazoles And Their Use As PI3K Inhibitors ASTRAZENECA AB (SE) 2008-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132502-A1 5-Heteroaryl Thiazoles And Their Use As PI3K Inhibitors MTOR, PIK3R5, PIK3CA PIK3CA 3/4885PIK3CB 18/4885PIK3CD 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.